Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2008
10/08/2008EP1032667B1 Platelet specific antigens and their pharmacological uses
10/08/2008EP1020518B1 Transporter genes
10/08/2008EP0804580B1 Calcium binding recombinant antibody against protein c
10/08/2008EP0752005B1 Compacted nucleic acids and their delivery to cells
10/08/2008CN101283093A Method for determination of SARS virus nucleocapsid protein, reagent kit for the determination, test device, monoclonal antibody directed against SARS virus nucleocapsid protein, and hybridoma capable
10/08/2008CN101282995A TCR-V-beta related peptides for treatment and diagnosis of autoimmune disease
10/08/2008CN101282994A Anti-CD26 antibodies and methods of use thereof
10/08/2008CN101282993A Antibodies directed to cd20 and uses thereof
10/08/2008CN101282992A Anti-myostatin antibodies
10/08/2008CN101282745A B-cell reduction using CD37-specific and CD20-specific binding molecules
10/08/2008CN101280016A Cocaine-and amphetamine-regulated transcript peptides single-chain antibody and application thereof
10/08/2008CN101280015A Preparation of soluble human selenium-containing single-chain abzyme
10/08/2008CN101280014A Anti-Cyclin D1 human single-chain antibody
10/08/2008CN101280013A Anti-amyloid antibodies, compositions, methods and uses
10/08/2008CN101280010A Shrimp allergen antishrimp allergen antibody and use thereof
10/08/2008CN101279093A Cancer modulation antibody
10/08/2008CN100424175C Methods and compositions for treating neoplasms by ERBB3
10/08/2008CN100424171C High purity venom fibrinolysin prepartion method and its pharmaceutical formulation
10/08/2008CN100423777C Glycoprotein compositions
10/08/2008CN100423776C Therapeutic agent
10/07/2008USRE40535 Light and heavy chains of given amino acid sequence; bind to antigen; radiolabeled; adminstration for diagnosis and treatment of cancer
10/07/2008US7432367 Diagnosis of diseases related to an alteration in the regulation or in the coding regions of the RBP-7 gene and for prognosis/diagnosis of an eventual treatment with agents acting on pathologies involving abnormal cell proliferation and/or abnormal cell differentiation.
10/07/2008US7432366 Moraxella catarrhalis BASB034 polypeptides and used thereof
10/07/2008US7432364 Polynucleotide which encodes human antibody that binds to tissue inhibitors of metalloproteases; used to diagnose and treat liver & cardiac fibrosis, alcoholic liver disease, acute coronary syndrome, lupus nephritis, glomerulosclerotic renal disease, benign prostate hypertrophy, colon and lung cancer
10/07/2008US7432361 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
10/07/2008US7432359 Recombinant human antibody that specifically attacks A33-expressing tumor cells with the use of antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity based on the immune system, and for which no human anti-humanized antibody is produced
10/07/2008US7432358 Oncogene, recombinant protein derived therefrom, and uses thereof
10/07/2008US7432357 Anti-cancer antibodies with reduced complement fixation
10/07/2008US7432356 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b
10/07/2008US7432348 Novel Protein Histidine Phosphatase Interacting Partner of 180 KD; polypeptides/polynucleotides in diagnostic assays;genetic engineering; identifying agonists and antagonists; conditions having PHPIP-180 imbalance; cardiovascular diseases; nervous system disorders; antitumor, - carcinogenic agents
10/07/2008US7432346 Gene expressed in prostate cancer
10/07/2008US7432345 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
10/07/2008US7432344 Porcine CTLA-4 for xenograft-specific immunosuppression
10/07/2008US7432343 MAIL: Molecule possessing Ankyrin repeats Induced by Lipopolysaccharide or I theta B-zeta; antigenic peptide; detection and treatment of carcinomas, especially metastatic breast cancer
10/07/2008US7432083 Method for in vitro molecular evolution of protein function
10/07/2008US7432077 High-affinity choline transporter
10/07/2008US7432067 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility
10/07/2008US7432061 Assays for measuring matrix metalloproteinase activities
10/07/2008US7432053 Fluorescent protein from Aequorea coerulscens and methods for using the same
10/07/2008US7432052 Method and identification of downstream mRNA ligands to FMRP and their role in fragile X syndrome and associated disorders
10/07/2008US7431936 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
10/07/2008US7431927 TNFα-neutralizing antibodies
10/07/2008US7431926 Tumor supressor gene p33ING2
10/07/2008US7431925 Internal image antibodies for optical imaging and therapy
10/07/2008US7431924 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal
10/07/2008US7431923 Cytotoxicity mediation of cells evidencing surface expression of CD63
10/07/2008CA2218515C Monoclonal antibodies against hiv-1 and vaccines made thereof
10/07/2008CA2173956C Dna encoding 1,3-beta-d glucan synthase subunits
10/07/2008CA2149319C Haemophilus outer membrane protein
10/05/2008CA2583999A1 Characterization of a mekk binding site and uses thereof
10/02/2008WO2008119071A1 Modulation of tumor microenvironment
10/02/2008WO2008118926A1 A non-destructive method to quantify and isolate antigen-specific b cells and uses thereof
10/02/2008WO2008118587A2 Therapeutic applications of activation of human antigen-presenting cells through dectin-1
10/02/2008WO2008118356A2 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
10/02/2008WO2008118090A1 Cartilage intermediate layer protein 2 c1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
10/02/2008WO2008118087A1 Peptide for differentiating osteoarthritis from rheumatoid arthritis and non-disease conditions
10/02/2008WO2008117646A1 Method for stabilization of antibody
10/02/2008WO2008117049A1 Human anti cd166 antibody binding human tumor cells
10/02/2008WO2008116956A2 Peptides with capacity for binding with interleukine 10 (il - 10)
10/02/2008WO2008116867A1 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
10/02/2008WO2008116775A1 Polypeptide recognized by anti hiv-1 gp41 antibodies isolated from highly hiv-1 exposed, non infected women
10/02/2008WO2008116316A1 Vector encoding therapeutic polypeptide and safety elements to clear transduced cells
10/02/2008WO2008116299A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
10/02/2008WO2008116265A1 Peptides with anitfungal activity
10/02/2008WO2008098115A3 Optimized igf-1r antibodies and methods of using the same
10/02/2008WO2008091798A3 Optimized ca9 antibodies and methods of using the same
10/02/2008WO2008073463A3 Methods and compositions for treating and monitoring treatment of il-13-associated disorders
10/02/2008WO2008067070A3 Compositions and methods for producing benzylisoquinolines alkaloids
10/02/2008WO2008063771A3 Anti-cd20 antibodies and methods of use
10/02/2008WO2008060363A3 Tumor associated markers in the diagnosis of prostate cancer
10/02/2008WO2008060331A3 Antibodies to sars coronavirus
10/02/2008WO2008058127A3 Agonist trkb antibodies and uses thereof
10/02/2008WO2008055703A9 Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates
10/02/2008WO2008054517A3 Immunosuppressant binding antibodies and methods of obtaining and using same
10/02/2008WO2008051505A8 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
10/02/2008WO2008036437A3 Novel gene disruptions, compositions and methods relating thereto
10/02/2008WO2008013996A3 Engineered microorganisms for increasing product yield in biotransformations, related methods and systems
10/02/2008WO2007149287A3 Transfer factor compositions and methods
10/02/2008WO2007140371A8 Antibodies and immunoconjugates and uses therefor
10/02/2008WO2007134327A3 Neutralizing antibodies to influenza viruses
10/02/2008WO2007120823A3 Uses and compositions for treatment of psoriasis
10/02/2008WO2007106744A8 Anti-5t4 antibodies and uses thereof
10/02/2008WO2005079490A3 Methods of therapy and diagnosis using targeting of cells that express steap2 polypeptides
10/02/2008WO2004081187A8 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
10/02/2008US20080244790 Methyl-d-erythritol phosphate pathway genes
10/02/2008US20080242845 Fc variants with optimized properties
10/02/2008US20080242844 Using ethanol extraction to isolate gamma globulin from plasma
10/02/2008US20080242843 Function of a haptoglobin-haemoglobin receptor and the uses thereof
10/02/2008US20080242840 Saposin B specific monoclonal antibody for use in treatment and prevention of cell proliferative disorders
10/02/2008US20080242839 Heterodimeric human cytokine receptor comprising Zcytor16/Zcytor11 components for use in treatment of cell proliferative, inflammatory and immune disorders
10/02/2008US20080242637 Binding efficiency;cyxicity; therapy for lung, colon, ovariers tumor
10/02/2008US20080242607 Glycosylation of peptides via o-linked glycosylation sequences
10/02/2008US20080242605 Prevent binding of formyl methionine-leucine-phenylalanine and, or protein to granulocytes; antiinflammatory agents; viricides; HIV infections
10/02/2008US20080242604 Nucleotide sequence coding protein; for therapy of periodontal disease; wound healing agent
10/02/2008US20080241961 Drosophila g protein coupled receptors, nucleic acids, and mehtods related to the same
10/02/2008US20080241960 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders
10/02/2008US20080241946 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders
10/02/2008US20080241945 Peptide for differentiating osteoarthritis from rheumatoid arthritis and non-disease conditions
10/02/2008US20080241934 Methods for reducing complexity of a sample using small epitope antibodies
10/02/2008US20080241924 Using cell adhesion molecule specific immunoglobulin for prevention and treatment of colon, breast and cervical cancers
1 ... 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 ... 1494